TrialJAMA dermatology2018

Targeting Tropomyosin Receptor Kinase in Cutaneous CYLD Defective Tumors With Pegcantratinib: The TRAC Randomized Clinical Trial.

Marina Danilenko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.